http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6607892-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-60 |
filingDate | 2002-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2003-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44e6a2365319f33bec7cac983217bafd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3f9ea805dae464d5d9632091d5dba27 |
publicationDate | 2003-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-6607892-B2 |
titleOfInvention | 21529, a novel adenylate cyclase |
abstract | Novel adenylate cyclase polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length adenylate cyclase proteins, the invention further provides isolated adenylate cyclase fusion proteins, antigenic peptides, and anti-adenylate cyclase antibodies. The invention also provides adenylate cyclase nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an adenylate cyclase gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9564356-B2 |
priorityDate | 1999-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 319.